Aprea Therapeutics, Inc.
APRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781983
No open-market purchases or sales by Aprea Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.
Holders of 5% or more of APRE
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Aprea Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Soleus Private Equity Fund III, L.P. | 13G | 9.99%1.27M shares | New | Apr 1, 20261 filing | Apr 1, 2026 | SEC |
| Vestal Point Capital, LP | 13G | 9.90%22.7M shares | New | May 15, 20261 filing | May 15, 2026 | SEC |
| Squadron Capital Management LLC | 13G | 9.90%1.27M shares | New | Apr 7, 20261 filing | Apr 7, 2026 | SEC |
| Hirschman Orin | 13G/A | 9.90%1.19M shares | 0.00 ppfrom 9.90% | Mar 3, 20235 filings | Apr 27, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
35 Schedule 13D and 13G filings on Aprea Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 13, 20262:27 PM ET | Lytton Laurence W | 13G/A | 3.20%390.8K shares | −6.70 ppfrom 9.90%Below 5% | Jun 30, 2026 | SEC |
| May 15, 20265:00 PM ET | Vestal Point Capital, LPand 1 other | 13G | 9.90%22.7M shares | New | Mar 31, 2026 | SEC |
| Apr 27, 20268:09 AM ET | Hirschman Orinand 1 other | 13G/A | 9.90%1.19M shares | 0.00 ppfrom 9.90% | Mar 31, 2026 | SEC |
| Apr 7, 20264:26 PM ET | Squadron Capital Management LLCand 3 others | 13G | 9.90%1.27M shares | New | Mar 30, 2026 | SEC |
| Apr 1, 20265:00 PM ET | Soleus Private Equity Fund III, L.P.and 8 others | 13G | 9.99%1.27M shares | New | Apr 1, 2026 | SEC |
| Feb 13, 20265:02 PM ET | Nantahala Capital Management, LLCand 2 others | 13G/A | 4.50%411.5K shares | −2.80 ppfrom 7.30%Below 5% | Dec 31, 2025 | SEC |
| Jan 28, 20262:02 PM ET | Hirschman Orinand 1 other | 13G/A | 9.90%651.7K shares | 0.00 ppfrom 9.90% | Dec 31, 2025 | SEC |
| Nov 17, 20257:16 PM ET | Lytton Laurence W | 13G | 9.90%681.8K shares | New | Nov 13, 2025 | SEC |
| Nov 12, 20258:00 AM ET | Sio Capital Management, LLC | 13G/A | 1.93%112.2K shares | −3.12 ppfrom 5.05%Below 5% | Sep 30, 2025 | SEC |
| Aug 13, 20252:00 PM ET | Sio Capital Management, LLC | 13G/A | 5.05%279.4K shares | +0.01 ppfrom 5.04% | Jun 30, 2025 | SEC |
| May 14, 20254:04 PM ET | Stonepine Capital Management, LLCand 3 others | 13G/A | 4.30%239.4K shares | −0.80 ppfrom 5.10%Below 5% | Mar 31, 2025 | SEC |
| Apr 8, 20253:14 PM ET | Sio Capital Management, LLC | 13G/A | 5.04%276.6K shares | −0.05 ppfrom 5.09% | Mar 31, 2025 | SEC |
| Feb 13, 202512:15 PM ET | Stonepine Capital Management, LLCand 3 others | 13G/A | 5.10%286.4K shares | – | Dec 31, 2024 | SEC |
| Feb 10, 202512:56 PM ET | Sio Capital Management, LLC | 13G/A | 5.09%276.6K shares | – | Dec 31, 2024 | SEC |
| Feb 10, 20258:36 AM ET | Hirschman Orinand 1 other | 13G/A | 9.90%539.3K shares | – | Dec 31, 2024 | SEC |
| Nov 14, 20244:53 PM ET | Nantahala Capital Management, LLCand 2 others | 13G | 7.30%411.5K shares | New | Sep 30, 2024 | SEC |
| Oct 10, 2024 | Stonepine Capital Management, LLC | 13GOld format | – | New | – | SEC |
| Feb 14, 2024 | Sio Capital Management, LLC | 13GOld format | – | New | – | SEC |
| Feb 7, 2024 | Hirschman Orin | 13G/AOld format | – | – | – | SEC |
| Mar 3, 2023 | Hirschman Orin | 13GOld format | – | New | – | SEC |
| Nov 15, 2022 | HealthCap VII, L.P. | 13D/AOld format | – | – | – | SEC |
| Jun 30, 2022 | HealthCap VII, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Redmile Group, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Versant Ventures V, LLC | 13G/AOld format | – | – | – | SEC |
| Oct 15, 2021 | HealthCap VII, L.P. | 13D/AOld format | – | – | – | SEC |
| Oct 12, 2021 | Morgan Stanley | 13G/AOld format | – | – | – | SEC |
| Mar 24, 2021 | Morgan Stanley | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Versant Ventures V, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | 5AM Ventures IV, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Redmile Group, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | KDev Investments AB | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Sectoral Asset Management Inc | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2021 | Janus Henderson Group PLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2021 | FMR LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Aprea Therapeutics, Inc. shares.
No Form 144 notices for Aprea Therapeutics, Inc. are on file.